Knight Therapeutics (TSX:GUD) Days Payable : 191.88 (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Knight Therapeutics Days Payable?

Knight Therapeutics's average Accounts Payable for the three months ended in Dec. 2023 was C$84.1 Mil. Knight Therapeutics's Cost of Goods Sold for the three months ended in Dec. 2023 was C$40.0 Mil. Hence, Knight Therapeutics's Days Payable for the three months ended in Dec. 2023 was 191.88.

The historical rank and industry rank for Knight Therapeutics's Days Payable or its related term are showing as below:

TSX:GUD' s Days Payable Range Over the Past 10 Years
Min: 92.66 Med: 181.75 Max: 653.7
Current: 197.83

During the past 11 years, Knight Therapeutics's highest Days Payable was 653.70. The lowest was 92.66. And the median was 181.75.

TSX:GUD's Days Payable is ranked better than
82.7% of 977 companies
in the Drug Manufacturers industry
Industry Median: 86.3 vs TSX:GUD: 197.83

Knight Therapeutics's Days Payable declined from Dec. 2022 (200.70) to Dec. 2023 (191.88). It may suggest that Knight Therapeutics accelerated paying its suppliers.

Knight Therapeutics Days Payable Historical Data

The historical data trend for Knight Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Knight Therapeutics Days Payable Chart

Knight Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

653.70

181.75

156.50

201.12

199.01

Knight Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															200.70	233.44	175.43	194.70	191.88

Competitive Comparison of Knight Therapeutics's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Knight Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Knight Therapeutics's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Knight Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Knight Therapeutics's Days Payable falls into.

Knight Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Knight Therapeutics's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (106.061	+	85.366)	/	2 )	/	175.547	*	365
=	95.7135					/	175.547	*	365
=	199.01

Knight Therapeutics's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (82.782	+	85.366)	/	2 )	/	39.982	*	365 / 4
=	84.074					/	39.982	*	365 / 4
=	191.88

Knight Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Knight Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Knight Therapeutics (TSX:GUD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Knight Therapeutics Inc (TSX:GUD) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

KHTRF:USA

Address

3400 De Maisonneuve West, Suite 1055, Montreal, QC, CAN, H3Z 3B8

Website

https://www.gud-knight.com

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Ltin America and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.

Executives

Sime Armoyan

10% Security Holder

Knight Therapeutics (TSX:GUD) Headlines

No Headlines